What happened

Japan Post Holdings Co., Ltd. sold 15,000 common shares of Aflac Inc (NYSE: AFL), making a small cut to its position. The Nov. 18 trades left nearly all of the stake intact for a shareholder listed as a 10% owner.

The sales totaled about $1.88 million, with most of the volume in the lower-priced group. Japan Post reported selling 13,650 shares at a weighted average of $125.54 per share and 1,350 shares at a weighted average of $126.38 per share.

Each weighted average covers multiple trades at different prices. Individual prices ranged from $125.17 to $126.17 per share in the larger group and from $126.18 to $126.68 per share in the smaller one.

The larger group left Japan Post with 50,025,749 shares before the smaller group reduced the balance again. In the Form 4 signed Nov. 20, Japan Post indicated that the sales were made under a Rule 10b5-1 trading plan.

Explain the financial terms

A Form 4 is the SEC report an officer, director or 10% owner files within two business days of buying or selling the company's stock.

A Rule 10b5-1 plan is a trading plan an insider sets up in advance, while not holding inside information, that schedules later trades.

Why it matters

The change in share count puts the sale proceeds in context. Japan Post’s reported position went from 50,039,399 shares immediately before the trades to 50,024,399 shares afterward.

That position is held indirectly through the J A Alliance Trust. J A Alliance Holdings Corporation holds the shares directly as trustee, rather than Japan Post holding them in its own name. The filing cites Japan Post’s role as the trust’s sole settlor and beneficiary as the basis for treating it as a potential beneficial owner. Japan Post disclaims beneficial ownership beyond its economic interest in the shares.

The trading plan limits what investors can infer about Japan Post’s view of the insurer from the sale. OptimistFi has focused on Aflac’s ability to turn supplemental insurance into steady cash returns through disciplined underwriting and investment management. The sale leaves that view unchanged.

What's next

Aflac’s next quarterly report is the next test, with weaker underwriting or investment results a more direct challenge to that view than the share sale.

Sources checked automatically Nov 20, 2026 · Human review: none
Thesis impactAFL: no published thesis yet.